

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.16131202 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.06989807 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.01117764 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.00331601 |
| 5 | axon ensheathment in central nervous system (GO:0032291) | 4.87904933 |
| 6 | central nervous system myelination (GO:0022010) | 4.87904933 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.71481873 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.66477599 |
| 9 | vocalization behavior (GO:0071625) | 4.62914659 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.49389425 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.43202383 |
| 12 | presynaptic membrane assembly (GO:0097105) | 4.40407866 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.35907536 |
| 14 | neuronal action potential propagation (GO:0019227) | 4.35593549 |
| 15 | transmission of nerve impulse (GO:0019226) | 4.33787169 |
| 16 | protein localization to synapse (GO:0035418) | 4.26022969 |
| 17 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.16325611 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.13282479 |
| 19 | glutamate secretion (GO:0014047) | 4.12108068 |
| 20 | presynaptic membrane organization (GO:0097090) | 4.08799452 |
| 21 | dendritic spine morphogenesis (GO:0060997) | 4.06912308 |
| 22 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.99896151 |
| 23 | L-amino acid import (GO:0043092) | 3.92193376 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 3.91342667 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 3.90234923 |
| 26 | exploration behavior (GO:0035640) | 3.88161005 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.82203524 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.79823654 |
| 29 | gamma-aminobutyric acid transport (GO:0015812) | 3.77744208 |
| 30 | neuron-neuron synaptic transmission (GO:0007270) | 3.71701862 |
| 31 | neuron recognition (GO:0008038) | 3.70315900 |
| 32 | layer formation in cerebral cortex (GO:0021819) | 3.69480317 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.66942196 |
| 34 | positive regulation of membrane potential (GO:0045838) | 3.66819485 |
| 35 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.63255755 |
| 36 | neuronal ion channel clustering (GO:0045161) | 3.59644934 |
| 37 | neurotransmitter secretion (GO:0007269) | 3.58240798 |
| 38 | regulation of synaptic vesicle transport (GO:1902803) | 3.55573748 |
| 39 | cerebellar granule cell differentiation (GO:0021707) | 3.50007983 |
| 40 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.48846603 |
| 41 | regulation of synapse structural plasticity (GO:0051823) | 3.48447152 |
| 42 | negative regulation of neurotransmitter transport (GO:0051589) | 3.46617040 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.45159952 |
| 44 | myelination (GO:0042552) | 3.44294331 |
| 45 | membrane depolarization during action potential (GO:0086010) | 3.43772495 |
| 46 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.43617559 |
| 47 | long-term memory (GO:0007616) | 3.42740895 |
| 48 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.42244851 |
| 49 | startle response (GO:0001964) | 3.41153390 |
| 50 | dendrite morphogenesis (GO:0048813) | 3.40034023 |
| 51 | axon ensheathment (GO:0008366) | 3.38278651 |
| 52 | ensheathment of neurons (GO:0007272) | 3.38278651 |
| 53 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.38176271 |
| 54 | positive regulation of synapse maturation (GO:0090129) | 3.36898438 |
| 55 | nucleobase catabolic process (GO:0046113) | 3.36751283 |
| 56 | postsynaptic membrane organization (GO:0001941) | 3.35998578 |
| 57 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.35867117 |
| 58 | axonal fasciculation (GO:0007413) | 3.34946373 |
| 59 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.33268690 |
| 60 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.33007708 |
| 61 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.28023753 |
| 62 | regulation of postsynaptic membrane potential (GO:0060078) | 3.27990911 |
| 63 | auditory behavior (GO:0031223) | 3.26827663 |
| 64 | adult walking behavior (GO:0007628) | 3.25369058 |
| 65 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.24588898 |
| 66 | establishment of mitochondrion localization (GO:0051654) | 3.22475568 |
| 67 | regulation of dendritic spine development (GO:0060998) | 3.21302078 |
| 68 | negative regulation of dendrite development (GO:2000171) | 3.21102362 |
| 69 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.19640613 |
| 70 | amino acid import (GO:0043090) | 3.18372082 |
| 71 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.18291283 |
| 72 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.16799302 |
| 73 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.16265627 |
| 74 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.14826930 |
| 75 | regulation of synaptic plasticity (GO:0048167) | 3.14278655 |
| 76 | neurotransmitter transport (GO:0006836) | 3.10455286 |
| 77 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.10001941 |
| 78 | long-term synaptic potentiation (GO:0060291) | 3.06878128 |
| 79 | retinal cone cell development (GO:0046549) | 3.06795570 |
| 80 | regulation of neurotransmitter secretion (GO:0046928) | 3.05409784 |
| 81 | regulation of vesicle fusion (GO:0031338) | 3.05406008 |
| 82 | positive regulation of dendritic spine development (GO:0060999) | 3.03556738 |
| 83 | membrane hyperpolarization (GO:0060081) | 3.03436625 |
| 84 | cell migration in hindbrain (GO:0021535) | 3.02171008 |
| 85 | glycosphingolipid biosynthetic process (GO:0006688) | 3.01575755 |
| 86 | serotonin metabolic process (GO:0042428) | 3.00123147 |
| 87 | response to auditory stimulus (GO:0010996) | 2.99851795 |
| 88 | neuronal action potential (GO:0019228) | 2.97619444 |
| 89 | neuromuscular process controlling balance (GO:0050885) | 2.97500978 |
| 90 | central nervous system neuron axonogenesis (GO:0021955) | 2.94789127 |
| 91 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.94416973 |
| 92 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.93865804 |
| 93 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.93595314 |
| 94 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.92942704 |
| 95 | prepulse inhibition (GO:0060134) | 2.92070097 |
| 96 | synapse assembly (GO:0007416) | 2.90575816 |
| 97 | learning (GO:0007612) | 2.90061659 |
| 98 | synaptic transmission (GO:0007268) | 2.89838303 |
| 99 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.89476635 |
| 100 | dendritic spine organization (GO:0097061) | 2.89283041 |
| 101 | regulation of neurotransmitter levels (GO:0001505) | 2.89094486 |
| 102 | neuromuscular synaptic transmission (GO:0007274) | 2.88337937 |
| 103 | cellular potassium ion homeostasis (GO:0030007) | 2.87603698 |
| 104 | membrane depolarization (GO:0051899) | 2.85908094 |
| 105 | regulation of synapse maturation (GO:0090128) | 2.85569302 |
| 106 | regulation of neurotransmitter transport (GO:0051588) | 2.85006975 |
| 107 | behavioral response to nicotine (GO:0035095) | 2.84763837 |
| 108 | negative regulation of axonogenesis (GO:0050771) | 2.84420683 |
| 109 | synaptic vesicle endocytosis (GO:0048488) | 2.83891444 |
| 110 | neurofilament cytoskeleton organization (GO:0060052) | 2.83711424 |
| 111 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.81388343 |
| 112 | primary amino compound metabolic process (GO:1901160) | 2.81018146 |
| 113 | synapse organization (GO:0050808) | 2.80571371 |
| 114 | regulation of glutamate secretion (GO:0014048) | 2.80322573 |
| 115 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.78355727 |
| 116 | mating behavior (GO:0007617) | 2.77437404 |
| 117 | neurotransmitter catabolic process (GO:0042135) | 2.77036435 |
| 118 | behavioral response to cocaine (GO:0048148) | 2.76235291 |
| 119 | establishment of synaptic vesicle localization (GO:0097480) | 2.75883849 |
| 120 | synaptic vesicle transport (GO:0048489) | 2.75883849 |
| 121 | regulation of dendrite morphogenesis (GO:0048814) | 2.75806381 |
| 122 | proline transport (GO:0015824) | 2.75688889 |
| 123 | sodium ion export (GO:0071436) | 2.75217104 |
| 124 | mechanosensory behavior (GO:0007638) | 2.75060652 |
| 125 | dendrite development (GO:0016358) | 2.74614257 |
| 126 | positive regulation of synapse assembly (GO:0051965) | 2.74564218 |
| 127 | neurotransmitter uptake (GO:0001504) | 2.74199544 |
| 128 | calcium ion-dependent exocytosis (GO:0017156) | 2.73485352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.07698173 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.71938600 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07222419 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.04535078 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99785904 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.64949972 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.64949972 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.61132021 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.53582572 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50943388 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47479988 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47135568 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46285755 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.44764321 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41875589 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32013429 |
| 17 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.31162076 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29706515 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27388643 |
| 20 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.25761050 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17516426 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.03916910 |
| 23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.96885099 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.95737550 |
| 25 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.94651158 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.85336196 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82357235 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75770565 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75714715 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70087119 |
| 31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.69119793 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68642094 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.62717942 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.60143498 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56918115 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.53265888 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.52256924 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50331764 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50009136 |
| 40 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48814365 |
| 41 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48562641 |
| 42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.48104534 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46424214 |
| 44 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.44831674 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44064987 |
| 46 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38229252 |
| 47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38145798 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36683573 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35444696 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33127247 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30168762 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29273864 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28073815 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27932355 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25363581 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25352374 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25178973 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24869741 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24445738 |
| 60 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.23212694 |
| 61 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.20989928 |
| 62 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20856491 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.19260654 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.18781646 |
| 65 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17304679 |
| 66 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.16513927 |
| 67 | FUS_26573619_Chip-Seq_HEK293_Human | 1.15934961 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14733890 |
| 69 | EWS_26573619_Chip-Seq_HEK293_Human | 1.14306608 |
| 70 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12992004 |
| 71 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.11140989 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.11093960 |
| 73 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.11093960 |
| 74 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10938817 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10404960 |
| 76 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.09889487 |
| 77 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09798776 |
| 78 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08857828 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08701161 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08172955 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06766922 |
| 82 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05839003 |
| 83 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05674681 |
| 84 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05651920 |
| 85 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04624056 |
| 86 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.04591559 |
| 87 | * AR_19668381_ChIP-Seq_PC3_Human | 1.04388996 |
| 88 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03688073 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02825813 |
| 90 | KDM2B_26808549_Chip-Seq_REH_Human | 1.02735746 |
| 91 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01340790 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01262155 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00290597 |
| 94 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99256600 |
| 95 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.98431084 |
| 96 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98398883 |
| 97 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.97342962 |
| 98 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97052772 |
| 99 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96284709 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95039442 |
| 101 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94811480 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94543690 |
| 103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92560887 |
| 104 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91655457 |
| 105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90227975 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90227975 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89556415 |
| 108 | JUN_21703547_ChIP-Seq_K562_Human | 0.87291030 |
| 109 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87061357 |
| 110 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.86896432 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86241371 |
| 112 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.85771037 |
| 113 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85218852 |
| 114 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85153437 |
| 115 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84512042 |
| 116 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84495402 |
| 117 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83961185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.67831726 |
| 2 | MP0003880_abnormal_central_pattern | 4.96438851 |
| 3 | MP0004270_analgesia | 4.07111154 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.75994936 |
| 5 | MP0009745_abnormal_behavioral_response | 3.28781880 |
| 6 | MP0002064_seizures | 3.14440977 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.00493786 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.99600915 |
| 9 | MP0002822_catalepsy | 2.93932699 |
| 10 | MP0009046_muscle_twitch | 2.90910951 |
| 11 | MP0001486_abnormal_startle_reflex | 2.84561556 |
| 12 | MP0002272_abnormal_nervous_system | 2.79741941 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.63837976 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.60085578 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.55139824 |
| 16 | MP0000920_abnormal_myelination | 2.29795926 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.25744693 |
| 18 | MP0000778_abnormal_nervous_system | 2.23336415 |
| 19 | MP0001529_abnormal_vocalization | 2.23214728 |
| 20 | MP0003329_amyloid_beta_deposits | 2.09237635 |
| 21 | MP0001501_abnormal_sleep_pattern | 1.99071143 |
| 22 | MP0002736_abnormal_nociception_after | 1.99013415 |
| 23 | MP0004885_abnormal_endolymph | 1.96477414 |
| 24 | MP0002735_abnormal_chemical_nociception | 1.92779193 |
| 25 | MP0001905_abnormal_dopamine_level | 1.90848083 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.90422823 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.90418356 |
| 28 | MP0001970_abnormal_pain_threshold | 1.85304239 |
| 29 | MP0008569_lethality_at_weaning | 1.80739008 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.78423088 |
| 31 | MP0004924_abnormal_behavior | 1.78423088 |
| 32 | MP0003690_abnormal_glial_cell | 1.75432500 |
| 33 | MP0000569_abnormal_digit_pigmentation | 1.70212714 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.67333976 |
| 35 | MP0004742_abnormal_vestibular_system | 1.65815869 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.65442154 |
| 37 | MP0000955_abnormal_spinal_cord | 1.64307763 |
| 38 | MP0002184_abnormal_innervation | 1.64011195 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.59144830 |
| 40 | MP0004142_abnormal_muscle_tone | 1.56668187 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.55844938 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.51251642 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.50044469 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.49824823 |
| 45 | MP0002066_abnormal_motor_capabilities/c | 1.49314264 |
| 46 | MP0001984_abnormal_olfaction | 1.43435175 |
| 47 | MP0005409_darkened_coat_color | 1.42957507 |
| 48 | MP0002102_abnormal_ear_morphology | 1.41785137 |
| 49 | MP0003634_abnormal_glial_cell | 1.41486464 |
| 50 | MP0001485_abnormal_pinna_reflex | 1.33454734 |
| 51 | MP0002229_neurodegeneration | 1.31570515 |
| 52 | MP0004858_abnormal_nervous_system | 1.30473246 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.30336212 |
| 54 | MP0003633_abnormal_nervous_system | 1.26803833 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.22705525 |
| 56 | MP0003631_nervous_system_phenotype | 1.22333712 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.18988671 |
| 58 | MP0003632_abnormal_nervous_system | 1.17555716 |
| 59 | MP0002152_abnormal_brain_morphology | 1.17316379 |
| 60 | MP0005171_absent_coat_pigmentation | 1.13388556 |
| 61 | MP0001188_hyperpigmentation | 1.09811511 |
| 62 | MP0003121_genomic_imprinting | 1.09410684 |
| 63 | MP0001963_abnormal_hearing_physiology | 1.06394738 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.04906078 |
| 65 | MP0003879_abnormal_hair_cell | 1.02929683 |
| 66 | MP0003787_abnormal_imprinting | 1.01255459 |
| 67 | MP0002752_abnormal_somatic_nervous | 1.00354810 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.96731038 |
| 69 | MP0003136_yellow_coat_color | 0.95103483 |
| 70 | MP0004145_abnormal_muscle_electrophysio | 0.94863595 |
| 71 | MP0002653_abnormal_ependyma_morphology | 0.90708643 |
| 72 | MP0000604_amyloidosis | 0.89575327 |
| 73 | MP0000631_abnormal_neuroendocrine_gland | 0.88698886 |
| 74 | MP0001177_atelectasis | 0.85587042 |
| 75 | MP0002069_abnormal_eating/drinking_beha | 0.85287450 |
| 76 | MP0005670_abnormal_white_adipose | 0.81843491 |
| 77 | MP0004133_heterotaxia | 0.81427129 |
| 78 | MP0005410_abnormal_fertilization | 0.81316480 |
| 79 | MP0002090_abnormal_vision | 0.81098769 |
| 80 | MP0008874_decreased_physiological_sensi | 0.79397614 |
| 81 | MP0002234_abnormal_pharynx_morphology | 0.78884411 |
| 82 | MP0000751_myopathy | 0.78536973 |
| 83 | MP0001299_abnormal_eye_distance/ | 0.77939345 |
| 84 | MP0004085_abnormal_heartbeat | 0.77386216 |
| 85 | MP0006292_abnormal_olfactory_placode | 0.75620431 |
| 86 | MP0008872_abnormal_physiological_respon | 0.74529220 |
| 87 | MP0005187_abnormal_penis_morphology | 0.72701305 |
| 88 | MP0004147_increased_porphyrin_level | 0.72421942 |
| 89 | MP0002751_abnormal_autonomic_nervous | 0.72141402 |
| 90 | MP0003137_abnormal_impulse_conducting | 0.71280058 |
| 91 | MP0003122_maternal_imprinting | 0.71088403 |
| 92 | MP0000026_abnormal_inner_ear | 0.71021338 |
| 93 | MP0005394_taste/olfaction_phenotype | 0.67398321 |
| 94 | MP0005499_abnormal_olfactory_system | 0.67398321 |
| 95 | MP0006072_abnormal_retinal_apoptosis | 0.67321650 |
| 96 | MP0005623_abnormal_meninges_morphology | 0.66815069 |
| 97 | MP0002876_abnormal_thyroid_physiology | 0.66764021 |
| 98 | MP0003119_abnormal_digestive_system | 0.65908317 |
| 99 | MP0003861_abnormal_nervous_system | 0.65737479 |
| 100 | MP0003938_abnormal_ear_development | 0.65701196 |
| 101 | MP0004215_abnormal_myocardial_fiber | 0.64613173 |
| 102 | MP0005535_abnormal_body_temperature | 0.63967123 |
| 103 | MP0001664_abnormal_digestion | 0.63478233 |
| 104 | MP0000462_abnormal_digestive_system | 0.63465947 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.63429125 |
| 106 | MP0003075_altered_response_to | 0.63309001 |
| 107 | MP0002638_abnormal_pupillary_reflex | 0.62436519 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.59950393 |
| 109 | MP0004043_abnormal_pH_regulation | 0.59743414 |
| 110 | MP0004130_abnormal_muscle_cell | 0.59136712 |
| 111 | MP0000427_abnormal_hair_cycle | 0.59135698 |
| 112 | MP0001943_abnormal_respiration | 0.58961147 |
| 113 | MP0005253_abnormal_eye_physiology | 0.56614556 |
| 114 | MP0003698_abnormal_male_reproductive | 0.55947493 |
| 115 | MP0008789_abnormal_olfactory_epithelium | 0.53684464 |
| 116 | MP0005195_abnormal_posterior_eye | 0.52127739 |
| 117 | MP0010769_abnormal_survival | 0.51725078 |
| 118 | MP0000747_muscle_weakness | 0.50756269 |
| 119 | MP0002082_postnatal_lethality | 0.49842514 |
| 120 | MP0010770_preweaning_lethality | 0.49842514 |
| 121 | MP0010768_mortality/aging | 0.48266449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.64200833 |
| 2 | Focal motor seizures (HP:0011153) | 6.36664729 |
| 3 | Focal seizures (HP:0007359) | 4.82052014 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.51102621 |
| 5 | Atonic seizures (HP:0010819) | 4.38412700 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.18024516 |
| 7 | Visual hallucinations (HP:0002367) | 4.03248208 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 3.97107752 |
| 9 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.89141676 |
| 10 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.89141676 |
| 11 | Abnormality of the corticospinal tract (HP:0002492) | 3.76088087 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 3.70047143 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.59831102 |
| 14 | Dysmetria (HP:0001310) | 3.55351425 |
| 15 | Action tremor (HP:0002345) | 3.54204210 |
| 16 | Spastic gait (HP:0002064) | 3.53861961 |
| 17 | Absence seizures (HP:0002121) | 3.47028496 |
| 18 | Broad-based gait (HP:0002136) | 3.35796447 |
| 19 | Ankle clonus (HP:0011448) | 3.35607558 |
| 20 | Dialeptic seizures (HP:0011146) | 3.34623298 |
| 21 | Febrile seizures (HP:0002373) | 3.27042985 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.26767202 |
| 23 | Intention tremor (HP:0002080) | 3.23088622 |
| 24 | Hyperventilation (HP:0002883) | 3.20312018 |
| 25 | Sensory axonal neuropathy (HP:0003390) | 3.19393667 |
| 26 | Dysdiadochokinesis (HP:0002075) | 3.02013102 |
| 27 | Scanning speech (HP:0002168) | 2.99431196 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 2.97681129 |
| 29 | Peripheral hypomyelination (HP:0007182) | 2.92507912 |
| 30 | Megalencephaly (HP:0001355) | 2.85523492 |
| 31 | Insidious onset (HP:0003587) | 2.84971802 |
| 32 | Termporal pattern (HP:0011008) | 2.84971802 |
| 33 | Akinesia (HP:0002304) | 2.81574046 |
| 34 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.80785198 |
| 35 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.80095604 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.72938351 |
| 37 | Anxiety (HP:0000739) | 2.71035900 |
| 38 | Status epilepticus (HP:0002133) | 2.68540808 |
| 39 | Abnormality of the labia minora (HP:0012880) | 2.65182665 |
| 40 | Progressive inability to walk (HP:0002505) | 2.64046133 |
| 41 | Hemiparesis (HP:0001269) | 2.63971475 |
| 42 | Amyotrophic lateral sclerosis (HP:0007354) | 2.60221812 |
| 43 | Poor eye contact (HP:0000817) | 2.52955366 |
| 44 | Truncal ataxia (HP:0002078) | 2.49841760 |
| 45 | Amblyopia (HP:0000646) | 2.49730234 |
| 46 | Depression (HP:0000716) | 2.47605359 |
| 47 | Mutism (HP:0002300) | 2.47291419 |
| 48 | Protruding tongue (HP:0010808) | 2.45783342 |
| 49 | Pheochromocytoma (HP:0002666) | 2.44894921 |
| 50 | Postural instability (HP:0002172) | 2.44041262 |
| 51 | Urinary urgency (HP:0000012) | 2.43207856 |
| 52 | Lower limb muscle weakness (HP:0007340) | 2.43083044 |
| 53 | Drooling (HP:0002307) | 2.37968181 |
| 54 | Excessive salivation (HP:0003781) | 2.37968181 |
| 55 | Limb dystonia (HP:0002451) | 2.37654870 |
| 56 | Aplasia involving bones of the extremities (HP:0009825) | 2.34326280 |
| 57 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.34326280 |
| 58 | Aplasia of the phalanges of the hand (HP:0009802) | 2.34326280 |
| 59 | Retinal dysplasia (HP:0007973) | 2.33905977 |
| 60 | Diplopia (HP:0000651) | 2.33215135 |
| 61 | Abnormality of binocular vision (HP:0011514) | 2.33215135 |
| 62 | Generalized myoclonic seizures (HP:0002123) | 2.32930090 |
| 63 | Thickened helices (HP:0000391) | 2.28755672 |
| 64 | Absent speech (HP:0001344) | 2.26915949 |
| 65 | Fetal akinesia sequence (HP:0001989) | 2.26581054 |
| 66 | Impaired social interactions (HP:0000735) | 2.26131799 |
| 67 | Abnormal social behavior (HP:0012433) | 2.26131799 |
| 68 | True hermaphroditism (HP:0010459) | 2.24596389 |
| 69 | Polyphagia (HP:0002591) | 2.20804172 |
| 70 | Medial flaring of the eyebrow (HP:0010747) | 2.17519818 |
| 71 | Pancreatic cysts (HP:0001737) | 2.16095293 |
| 72 | Neuroendocrine neoplasm (HP:0100634) | 2.15718307 |
| 73 | Pancreatic fibrosis (HP:0100732) | 2.15300416 |
| 74 | Onion bulb formation (HP:0003383) | 2.15143518 |
| 75 | Torticollis (HP:0000473) | 2.15105998 |
| 76 | Abnormality of midbrain morphology (HP:0002418) | 2.06589427 |
| 77 | Molar tooth sign on MRI (HP:0002419) | 2.06589427 |
| 78 | Stereotypic behavior (HP:0000733) | 2.05525393 |
| 79 | Absent/shortened dynein arms (HP:0200106) | 2.04045540 |
| 80 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.04045540 |
| 81 | Epileptiform EEG discharges (HP:0011182) | 2.03496948 |
| 82 | Alacrima (HP:0000522) | 2.03111540 |
| 83 | Lissencephaly (HP:0001339) | 2.02417100 |
| 84 | Impaired smooth pursuit (HP:0007772) | 2.02165983 |
| 85 | Congenital stationary night blindness (HP:0007642) | 1.99737977 |
| 86 | Congenital primary aphakia (HP:0007707) | 1.98971325 |
| 87 | Split foot (HP:0001839) | 1.98352612 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 1.98221128 |
| 89 | Clonus (HP:0002169) | 1.97523156 |
| 90 | Focal dystonia (HP:0004373) | 1.96226421 |
| 91 | Hypoplasia of the corpus callosum (HP:0002079) | 1.96165900 |
| 92 | Nephronophthisis (HP:0000090) | 1.94565314 |
| 93 | Genital tract atresia (HP:0001827) | 1.93794634 |
| 94 | Type II lissencephaly (HP:0007260) | 1.93226407 |
| 95 | Genetic anticipation (HP:0003743) | 1.91568457 |
| 96 | Blue irides (HP:0000635) | 1.91127981 |
| 97 | Clumsiness (HP:0002312) | 1.90394326 |
| 98 | Hypsarrhythmia (HP:0002521) | 1.90221112 |
| 99 | Spastic tetraparesis (HP:0001285) | 1.88421719 |
| 100 | Inability to walk (HP:0002540) | 1.86618169 |
| 101 | Gait imbalance (HP:0002141) | 1.86067483 |
| 102 | Esotropia (HP:0000565) | 1.86060645 |
| 103 | Increased circulating renin level (HP:0000848) | 1.85918410 |
| 104 | Pachygyria (HP:0001302) | 1.85794796 |
| 105 | Cerebral hypomyelination (HP:0006808) | 1.85594104 |
| 106 | Bradykinesia (HP:0002067) | 1.84112969 |
| 107 | Neuronal loss in central nervous system (HP:0002529) | 1.83872597 |
| 108 | Hemiplegia (HP:0002301) | 1.83397604 |
| 109 | Parakeratosis (HP:0001036) | 1.82981056 |
| 110 | Bowel incontinence (HP:0002607) | 1.82867604 |
| 111 | Vaginal atresia (HP:0000148) | 1.81718473 |
| 112 | Optic nerve hypoplasia (HP:0000609) | 1.81603015 |
| 113 | Impaired vibratory sensation (HP:0002495) | 1.81341048 |
| 114 | Papilledema (HP:0001085) | 1.81184878 |
| 115 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.81052799 |
| 116 | Nephrogenic diabetes insipidus (HP:0009806) | 1.80778313 |
| 117 | Specific learning disability (HP:0001328) | 1.80497255 |
| 118 | Slow saccadic eye movements (HP:0000514) | 1.78204173 |
| 119 | Failure to thrive in infancy (HP:0001531) | 1.77823625 |
| 120 | Spastic tetraplegia (HP:0002510) | 1.77478009 |
| 121 | Abnormality of saccadic eye movements (HP:0000570) | 1.77158656 |
| 122 | Sleep apnea (HP:0010535) | 1.77141691 |
| 123 | Abnormality of salivation (HP:0100755) | 1.75732784 |
| 124 | Delusions (HP:0000746) | 1.75415248 |
| 125 | Psychosis (HP:0000709) | 1.74219774 |
| 126 | Incomplete penetrance (HP:0003829) | 1.73802541 |
| 127 | Craniofacial dystonia (HP:0012179) | 1.72825073 |
| 128 | Exotropia (HP:0000577) | 1.72761459 |
| 129 | Congenital sensorineural hearing impairment (HP:0008527) | 1.72374054 |
| 130 | Paraplegia (HP:0010550) | 1.70864376 |
| 131 | Oligodactyly (hands) (HP:0001180) | 1.70497433 |
| 132 | Intellectual disability, severe (HP:0010864) | 1.70287209 |
| 133 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.69789759 |
| 134 | Pendular nystagmus (HP:0012043) | 1.69354528 |
| 135 | CNS hypomyelination (HP:0003429) | 1.68988519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.22255920 |
| 2 | NTRK3 | 3.33808507 |
| 3 | FRK | 3.22445333 |
| 4 | MARK1 | 3.12875787 |
| 5 | STK39 | 2.92520377 |
| 6 | TNIK | 2.86749606 |
| 7 | MAP3K9 | 2.86207518 |
| 8 | OXSR1 | 2.58034703 |
| 9 | CASK | 2.40040070 |
| 10 | PAK6 | 2.18817314 |
| 11 | MAP3K4 | 2.16661146 |
| 12 | CDK19 | 2.12005775 |
| 13 | MINK1 | 2.07306304 |
| 14 | NTRK1 | 2.05133348 |
| 15 | NTRK2 | 2.02696338 |
| 16 | MAP4K2 | 1.93899604 |
| 17 | PRPF4B | 1.80224414 |
| 18 | MAP2K7 | 1.79272981 |
| 19 | PNCK | 1.70910729 |
| 20 | DAPK2 | 1.64803422 |
| 21 | KSR2 | 1.63800441 |
| 22 | UHMK1 | 1.62854043 |
| 23 | CDK5 | 1.55782163 |
| 24 | TYRO3 | 1.55768358 |
| 25 | MAPK13 | 1.50499104 |
| 26 | PRKD3 | 1.44938876 |
| 27 | BCR | 1.35829328 |
| 28 | FES | 1.31853313 |
| 29 | PKN1 | 1.28749662 |
| 30 | NEK6 | 1.25755915 |
| 31 | ARAF | 1.23527685 |
| 32 | WNK4 | 1.21186311 |
| 33 | KSR1 | 1.19987257 |
| 34 | GRK5 | 1.19320887 |
| 35 | CAMK2B | 1.16116407 |
| 36 | MAP3K12 | 1.14840870 |
| 37 | PHKG2 | 1.13937145 |
| 38 | PHKG1 | 1.13937145 |
| 39 | SGK494 | 1.13517611 |
| 40 | SGK223 | 1.13517611 |
| 41 | RIPK4 | 1.13428856 |
| 42 | MAP2K4 | 1.12765544 |
| 43 | WNK1 | 1.12553380 |
| 44 | FGR | 1.11830075 |
| 45 | CSNK1G2 | 1.10121293 |
| 46 | ICK | 1.05652218 |
| 47 | CAMK2A | 1.05367691 |
| 48 | CDK14 | 1.05237777 |
| 49 | PLK2 | 1.05037506 |
| 50 | CDK15 | 1.03525222 |
| 51 | CDK18 | 1.02550678 |
| 52 | TRIM28 | 1.02542693 |
| 53 | CAMKK1 | 1.01451705 |
| 54 | PRKCG | 0.98039094 |
| 55 | FGFR2 | 0.96852505 |
| 56 | PAK3 | 0.95316975 |
| 57 | MAP3K13 | 0.95044563 |
| 58 | MARK2 | 0.92695421 |
| 59 | CDK11A | 0.91715742 |
| 60 | ADRBK2 | 0.90898193 |
| 61 | CSNK1G3 | 0.90212327 |
| 62 | LIMK1 | 0.88384997 |
| 63 | MAP3K2 | 0.87340056 |
| 64 | ROCK2 | 0.86620957 |
| 65 | STK11 | 0.86106682 |
| 66 | SIK2 | 0.80629501 |
| 67 | INSRR | 0.80489149 |
| 68 | CCNB1 | 0.80191264 |
| 69 | CSNK1A1L | 0.77518578 |
| 70 | CAMK2D | 0.77355734 |
| 71 | DYRK1A | 0.73791755 |
| 72 | CAMK4 | 0.72526527 |
| 73 | MAPKAPK5 | 0.72515184 |
| 74 | GRK1 | 0.72088602 |
| 75 | BMPR2 | 0.68852604 |
| 76 | CAMK2G | 0.65054803 |
| 77 | PDPK1 | 0.64553218 |
| 78 | PRKCH | 0.64007360 |
| 79 | BMPR1B | 0.63824114 |
| 80 | PRKCE | 0.63260388 |
| 81 | PTK2B | 0.62495647 |
| 82 | NME1 | 0.62385970 |
| 83 | FYN | 0.61994356 |
| 84 | TAOK3 | 0.61609401 |
| 85 | RAF1 | 0.61458143 |
| 86 | CAMK1 | 0.61324506 |
| 87 | DAPK1 | 0.60564517 |
| 88 | MAP2K6 | 0.59658593 |
| 89 | SGK1 | 0.59560357 |
| 90 | CSNK1G1 | 0.57908180 |
| 91 | ERBB3 | 0.57222753 |
| 92 | DYRK2 | 0.56820118 |
| 93 | CAMKK2 | 0.53176243 |
| 94 | CSNK1D | 0.52081987 |
| 95 | ADRBK1 | 0.51983504 |
| 96 | MUSK | 0.50468023 |
| 97 | PDK1 | 0.49765630 |
| 98 | PRKCQ | 0.49270494 |
| 99 | PINK1 | 0.47871194 |
| 100 | PRKACA | 0.46371118 |
| 101 | WNK3 | 0.46285510 |
| 102 | TAOK2 | 0.45904636 |
| 103 | RET | 0.45580252 |
| 104 | SGK2 | 0.44666705 |
| 105 | IRAK2 | 0.44228276 |
| 106 | GRK7 | 0.43563769 |
| 107 | TAOK1 | 0.43005945 |
| 108 | CSNK1A1 | 0.41914604 |
| 109 | TNK2 | 0.41573400 |
| 110 | EPHB1 | 0.41197493 |
| 111 | MAPK12 | 0.41135498 |
| 112 | PRKCZ | 0.40991357 |
| 113 | RPS6KA3 | 0.40643410 |
| 114 | STK38 | 0.40222825 |
| 115 | CAMK1G | 0.40154490 |
| 116 | MAPK10 | 0.40118798 |
| 117 | DMPK | 0.39593554 |
| 118 | PRKG1 | 0.39414707 |
| 119 | SGK3 | 0.36636815 |
| 120 | PRKCA | 0.35783565 |
| 121 | PRKACB | 0.33358032 |
| 122 | CAMK1D | 0.33314877 |
| 123 | LMTK2 | 0.32753770 |
| 124 | GSK3B | 0.31974963 |
| 125 | MAPK8 | 0.31787939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.51382620 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.82136763 |
| 3 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.76169852 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.74576281 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.64894544 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.51838810 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.50806497 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.40015191 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.31628108 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.17687050 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.10534895 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05493808 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.95225926 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.92771432 |
| 15 | Long-term depression_Homo sapiens_hsa04730 | 1.86670910 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75975803 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74478001 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.73751108 |
| 19 | Axon guidance_Homo sapiens_hsa04360 | 1.72233463 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.71220897 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.65648272 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.56024166 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.54871916 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51719890 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50156193 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.49136092 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47024451 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.44396336 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.36783270 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35520750 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.32673630 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.27899626 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.27602549 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24005919 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21455589 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17986271 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16941040 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16069886 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06157367 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05138484 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.04910965 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.03552809 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.03515007 |
| 44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.02534659 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01857956 |
| 46 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01710473 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 0.97856335 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 0.97486618 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96811693 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93298097 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.92818471 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92774378 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91035456 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90949171 |
| 55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90579982 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87387246 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86707915 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84116053 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80889740 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80619314 |
| 61 | Glioma_Homo sapiens_hsa05214 | 0.79183319 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78365452 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78356699 |
| 64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78201288 |
| 65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.77605368 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73934025 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73719700 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73196196 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70484562 |
| 70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68131284 |
| 71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67318356 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67224491 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66375824 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.64982280 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64368496 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.63814377 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.63693619 |
| 78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63119035 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62113130 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.60671749 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60298012 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60283354 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.60218369 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59233659 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57930538 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56965526 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51404954 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.50358246 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48114507 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47994058 |
| 91 | Tight junction_Homo sapiens_hsa04530 | 0.47084735 |
| 92 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45237072 |
| 93 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43733312 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43316106 |
| 95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43074262 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.42376561 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40567088 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40511800 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37987934 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37825688 |
| 101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.35987147 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.35677454 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35561111 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35324853 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.35277387 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35186930 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33620456 |
| 108 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32555364 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32439513 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32241832 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31713343 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31588704 |
| 113 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31191246 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30914545 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30231328 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28116873 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23838552 |
| 118 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.23816096 |

